OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe, Masashi Aoki, Shoji Tsuji, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 7, pp. 505-512
Closed Access | Times Cited: 804
Koji Abe, Masashi Aoki, Shoji Tsuji, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 7, pp. 505-512
Closed Access | Times Cited: 804
Showing 1-25 of 804 citing articles:
Amyotrophic lateral sclerosis
Orla Hardiman, Ammar Al‐Chalabi, Adriano Chiò, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 1110
Orla Hardiman, Ammar Al‐Chalabi, Adriano Chiò, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 1110
Amyotrophic lateral sclerosis: a clinical review
Pegah Masrori, Philip Van Damme
European Journal of Neurology (2020) Vol. 27, Iss. 10, pp. 1918-1929
Open Access | Times Cited: 808
Pegah Masrori, Philip Van Damme
European Journal of Neurology (2020) Vol. 27, Iss. 10, pp. 1918-1929
Open Access | Times Cited: 808
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Nature (2019) Vol. 572, Iss. 7770, pp. 474-480
Open Access | Times Cited: 567
Eran Blacher, Stavros Bashiardes, Hagit Shapiro, et al.
Nature (2019) Vol. 572, Iss. 7770, pp. 474-480
Open Access | Times Cited: 567
Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 562
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 562
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Ruth Chia, Adriano Chiò, Bryan J. Traynor
The Lancet Neurology (2017) Vol. 17, Iss. 1, pp. 94-102
Open Access | Times Cited: 507
Ruth Chia, Adriano Chiò, Bryan J. Traynor
The Lancet Neurology (2017) Vol. 17, Iss. 1, pp. 94-102
Open Access | Times Cited: 507
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 471
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 471
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 10, pp. 919-930
Open Access | Times Cited: 443
Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 10, pp. 919-930
Open Access | Times Cited: 443
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Manoj K. Jaiswal
Medicinal Research Reviews (2018) Vol. 39, Iss. 2, pp. 733-748
Closed Access | Times Cited: 376
Manoj K. Jaiswal
Medicinal Research Reviews (2018) Vol. 39, Iss. 2, pp. 733-748
Closed Access | Times Cited: 376
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Ying Meng, Kullervo Hynynen, Nir Lipsman
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 7-22
Closed Access | Times Cited: 332
Ying Meng, Kullervo Hynynen, Nir Lipsman
Nature Reviews Neurology (2020) Vol. 17, Iss. 1, pp. 7-22
Closed Access | Times Cited: 332
Amyotrophic Lateral Sclerosis: An Update for 2018
Björn Oskarsson, Tania F. Gendron, Nathan P. Staff
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 11, pp. 1617-1628
Open Access | Times Cited: 291
Björn Oskarsson, Tania F. Gendron, Nathan P. Staff
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 11, pp. 1617-1628
Open Access | Times Cited: 291
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 269
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 269
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 255
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 255
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 231
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 231
Energy metabolism in ALS: an underappreciated opportunity?
Tijs Vandoorne, Katrien De Bock, Ludo Van Den Bosch
Acta Neuropathologica (2018) Vol. 135, Iss. 4, pp. 489-509
Open Access | Times Cited: 224
Tijs Vandoorne, Katrien De Bock, Ludo Van Den Bosch
Acta Neuropathologica (2018) Vol. 135, Iss. 4, pp. 489-509
Open Access | Times Cited: 224
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
Dean G. Brown, Heike J. Wobst
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2312-2338
Closed Access | Times Cited: 220
Dean G. Brown, Heike J. Wobst
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2312-2338
Closed Access | Times Cited: 220
How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
Kazutoshi Watanabe, Masahiko Tanaka, Satoshi Yuki, et al.
Journal of Clinical Biochemistry and Nutrition (2017) Vol. 62, Iss. 1, pp. 20-38
Open Access | Times Cited: 193
Kazutoshi Watanabe, Masahiko Tanaka, Satoshi Yuki, et al.
Journal of Clinical Biochemistry and Nutrition (2017) Vol. 62, Iss. 1, pp. 20-38
Open Access | Times Cited: 193
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesús S. Mora, Angela Genge, Adriano Chiò, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 21, Iss. 1-2, pp. 5-14
Open Access | Times Cited: 188
Jesús S. Mora, Angela Genge, Adriano Chiò, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 21, Iss. 1-2, pp. 5-14
Open Access | Times Cited: 188
Edaravone: A new drug approved for ALS
Jeffrey D. Rothstein
Cell (2017) Vol. 171, Iss. 4, pp. 725-725
Open Access | Times Cited: 186
Jeffrey D. Rothstein
Cell (2017) Vol. 171, Iss. 4, pp. 725-725
Open Access | Times Cited: 186
Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities
Ligia Akemi Kiyuna, Rudá Prestes e Albuquerque, Che‐Hong Chen, et al.
Free Radical Biology and Medicine (2018) Vol. 129, pp. 155-168
Open Access | Times Cited: 169
Ligia Akemi Kiyuna, Rudá Prestes e Albuquerque, Che‐Hong Chen, et al.
Free Radical Biology and Medicine (2018) Vol. 129, pp. 155-168
Open Access | Times Cited: 169
Treatment of a Mouse Model of ALS by In Vivo Base Editing
Colin K.W. Lim, Michael Gapinske, Alexandra K. Brooks, et al.
Molecular Therapy (2020) Vol. 28, Iss. 4, pp. 1177-1189
Open Access | Times Cited: 166
Colin K.W. Lim, Michael Gapinske, Alexandra K. Brooks, et al.
Molecular Therapy (2020) Vol. 28, Iss. 4, pp. 1177-1189
Open Access | Times Cited: 166
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke
Jie Xu, Anxin Wang, Xia Meng, et al.
Stroke (2021) Vol. 52, Iss. 3, pp. 772-780
Open Access | Times Cited: 150
Jie Xu, Anxin Wang, Xia Meng, et al.
Stroke (2021) Vol. 52, Iss. 3, pp. 772-780
Open Access | Times Cited: 150
Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, et al.
Muscle & Nerve (2020) Vol. 63, Iss. 1, pp. 31-39
Open Access | Times Cited: 149
Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, et al.
Muscle & Nerve (2020) Vol. 63, Iss. 1, pp. 31-39
Open Access | Times Cited: 149
Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Annals of Neurology (2019) Vol. 87, Iss. 2, pp. 206-216
Closed Access | Times Cited: 148
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Annals of Neurology (2019) Vol. 87, Iss. 2, pp. 206-216
Closed Access | Times Cited: 148
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis
Simon Witzel, André Maier, Robert Steinbach, et al.
JAMA Neurology (2022) Vol. 79, Iss. 2, pp. 121-121
Open Access | Times Cited: 142
Simon Witzel, André Maier, Robert Steinbach, et al.
JAMA Neurology (2022) Vol. 79, Iss. 2, pp. 121-121
Open Access | Times Cited: 142
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 137
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 137
